Literature DB >> 11135066

Clusterin is up-regulated in glomerular mesangial cells in complement-mediated injury.

K Yamada1, Y Hori, N Hanafusa, T Okuda, N Nagano, N H Choi-Miura, W G Couser, T Miyata, K Kurokawa, T Fujita, M Nangaku.   

Abstract

BACKGROUND: Clusterin is a soluble complement regulatory protein that binds to C5b-7 and inhibits generation of membrane attack complex, C5b-9. Glomerular deposition of clusterin has been observed in human and experimental membranous nephropathy in association with C5b-9 and immune deposits. However, it is controversial as to whether clusterin observed in glomeruli is synthesized by the resident glomerular cells or is derived from the circulation. We examined whether clusterin is expressed by resident glomerular cells exposed to complement-mediated injury.
METHODS: In vitro, cultured mesangial cells were exposed to antithymocyte serum immunoglobulin G and 5% normal rat serum as a complement source. In vivo, we induced anti-Thy1 nephritis in rats and examined the kidneys on days 8 and 29.
RESULTS: We observed increased expression of clusterin in cultured rat glomerular mesangial cells stimulated by sublytic complement attack. We also demonstrated that in comparison with control rats, both a marked increase in clusterin mRNA in the glomeruli and marked deposition of clusterin protein in the mesangial area occurred in the OX-7-treated rats on day 8 in association with C5b-9 deposition and on day 29.
CONCLUSION: Clusterin was induced in glomerular mesangial cells during the course of immune-mediated injuries. This up-regulation of clusterin may play a critical role in protecting mesangial cells from complement attack.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11135066     DOI: 10.1046/j.1523-1755.2001.00474.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  17 in total

Review 1.  Complement regulation and kidney diseases: recent knowledge of the double-edged roles of complement activation in nephrology.

Authors:  Masashi Mizuno; Yasuhiro Suzuki; Yasuhiko Ito
Journal:  Clin Exp Nephrol       Date:  2017-03-24       Impact factor: 2.801

2.  Clusterin attenuates the development of renal fibrosis.

Authors:  Gwon-Soo Jung; Mi-Kyung Kim; Yun-A Jung; Hye-Soon Kim; In-Sun Park; Bon-Hong Min; Ki-Up Lee; Jung-Guk Kim; Keun-Gyu Park; In-Kyu Lee
Journal:  J Am Soc Nephrol       Date:  2011-11-03       Impact factor: 10.121

3.  siRNA-based therapy ameliorates glomerulonephritis.

Authors:  Hideki Shimizu; Yuichi Hori; Shinya Kaname; Koei Yamada; Nobuhiro Nishiyama; Satoru Matsumoto; Kanjiro Miyata; Makoto Oba; Akira Yamada; Kazunori Kataoka; Toshiro Fujita
Journal:  J Am Soc Nephrol       Date:  2010-03-04       Impact factor: 10.121

4.  Apolipoprotein J/clusterin prevents a progressive glomerulopathy of aging.

Authors:  Mark E Rosenberg; Richard Girton; David Finkel; David Chmielewski; Arthur Barrie; David P Witte; Guang Zhu; John J Bissler; Judith A K Harmony; Bruce J Aronow
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

5.  The effects of ACE inhibitor and angiotensin receptor blocker on clusterin and apoptosis in the kidney tissue of streptozotocin-diabetic rats.

Authors:  Matem Tunçdemir; Melek Ozturk
Journal:  J Mol Histol       Date:  2008-10-24       Impact factor: 2.611

6.  Clusterin/apolipoprotein J attenuates angiotensin II-induced renal fibrosis.

Authors:  Gwon-Soo Jung; Jae-Han Jeon; Yun-A Jung; Yeon-Kyung Choi; Hye-Soon Kim; Jung-Guk Kim; Keun-Gyu Park; Mi-Kyung Kim; In-Kyu Lee
Journal:  PLoS One       Date:  2014-08-22       Impact factor: 3.240

7.  A pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (H.P. Acthar® Gel) in nephrotic syndrome due to idiopathic membranous nephropathy.

Authors:  Michelle A Hladunewich; Daniel Cattran; Laurence H Beck; Ayodele Odutayo; Sanjeev Sethi; Rivka Ayalon; Nelson Leung; Heather Reich; Fernando C Fervenza
Journal:  Nephrol Dial Transplant       Date:  2014-04-08       Impact factor: 5.992

8.  Relationship of clusterin with renal inflammation and fibrosis after the recovery phase of ischemia-reperfusion injury.

Authors:  Jia Guo; Qiunong Guan; Xiuheng Liu; Hao Wang; Martin E Gleave; Christopher Y C Nguan; Caigan Du
Journal:  BMC Nephrol       Date:  2016-09-20       Impact factor: 2.388

9.  Investigation of the Mechanism of Complement System in Diabetic Nephropathy via Bioinformatics Analysis.

Authors:  Bojun Xu; Lei Wang; Huakui Zhan; Liangbin Zhao; Yuehan Wang; Meng Shen; Keyang Xu; Li Li; Xu Luo; Shasha Zhou; Anqi Tang; Gang Liu; Lu Song; Yan Li
Journal:  J Diabetes Res       Date:  2021-05-24       Impact factor: 4.011

10.  Mass spectrometry assays of plasma biomarkers to predict radiographic progression of knee osteoarthritis.

Authors:  Susan Y Ritter; Jamie Collins; Bryan Krastins; David Sarracino; Mary Lopez; Elena Losina; Antonios O Aliprantis
Journal:  Arthritis Res Ther       Date:  2014-10-07       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.